...mall cell lung cancer [中国肺癌杂志 Chinese Journal of Lung Cancer] 肺癌的靶向治疗 [浙江医学 Zhejiang Medical Journal] 肺癌分子靶向治疗:个体化治疗的选择 [中国处方药 China Prescription Drug] ..
基于2个网页-相关网页
另外的靶向治疗在于能干扰肺癌细胞繁殖过程中的信号通路。
Other targeted therapies interrupt the signals that cause lung cancer cells to multiply, as shown in the highly magnified image here.
肺癌中表皮生长因子受体的突变及对靶向治疗的敏感性。
Epidermal growth factor receptor mutations and susceptibility to targeted therapy in lung cancer.
KRAS基因突变在恶性肿瘤组织中频发，可预测非小细胞肺癌分子靶向治疗的疗效和预后，针对RAS基因的分子抑制剂研究仍处于初级阶段。
KRAS mutation frequency in tumor tissue, can be predicted non-small cell lung cancer molecular targeted therapy efficacy and prognosis, and molecular inhibitors of RAS genes is still in its infancy.
应用推荐